OPTIDRAIN
Live / Applied — First extension granted (statement of use) (as of 19 Nov 2025)
What this means for you
Not registered yet, but its 20 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99049671
- Mark type
- Stylized text
- Filed
- 20 Feb 2025
- Published for opposition
- 08 Apr 2025
- Attorney of record
- Nichole Hayden
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic pharmaceuticals, namely, eye drops, solutions, gels, and ointments used for the treatment of eye conditions, including dry eyes, allergies, infection, inflammation, redness and corneal swelling.
Owner
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
Prosecution history
- 20 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2025 — SOU EXTENSION 1 GRANTED
- 19 Nov 2025 — SOU EXTENSION 1 FILED
- 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Mar 2025 — ASSIGNED TO EXAMINER
- 20 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 20 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Feb 2025 — NEW APPLICATION ENTERED